← Leaderboards
Nicholas Alexander Graham
University Of Southern California
$1,481,133
Attributed
$2,962,265
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $981.5K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,962,265 · 2
By mechanism
U01$2,526,052 · 1
R21$436,213 · 1
Top collaborators
- Stacey Deleria Finley4 shared
- Terry Torao Takahashi2 shared
Most similar at University Of Southern California
Same institution · by research overlap
- Gregory Darin Field$6,654,896
- Robert C Seeger$12,536,093
- Ole A Andreassen$1,548,163
- Terry Torao Takahashi$814,748
- Paul T Macklin$1,736,029
Others in their field
Other Rising Stars on “Libraries”
- Kevin V Grimes · Stanford University$14,783,804
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Heinz Ernst Moser · University Of Texas Med Br Galveston$13,657,841
- Joseph Fraser Glickman · Hackensack University Medical Center$8,363,749
- Fumiaki Yokokawa · University Of Texas Med Br Galveston$7,180,989
- Moustafa Gabr · Weill Medical Coll Of Cornell Univ$6,931,223
Research focus
LibrariesCellsDesignComplexEngineeringSignal TransductionMass Spectrum AnalysisSiteAntigensData SetEffector CellB-LymphocytesCancer CellCancer ImmunotherapyEngineered T CellsCytotoxicCell PhysiologyCytokineCytotoxicityCell-Mediated CytolysisCell TypeCellular BiologyCell MaturationCell Killing
Grant awards (6)
Modeling based design of chimeric antigen receptors for Natural Killer cell-based immunotherapy$981,496
U01 · FY2025 · CA
Modeling based design of chimeric antigen receptors for Natural Killer cell-based immunotherapy$495,564
U01 · FY2024 · CA
Modeling based design of chimeric antigen receptors for Natural Killer cell-based immunotherapy$513,835
U01 · FY2023 · CA
Developing novel affinity reagents for methyl-arginine proteomics using mRNA display$197,352
R21 · FY2023 · GM · contact PI
Modeling based design of chimeric antigen receptors for Natural Killer cell-based immunotherapy$535,157
U01 · FY2022 · CA
Developing novel affinity reagents for methyl-arginine proteomics using mRNA display$238,861
R21 · FY2022 · GM · contact PI